Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-24-006482
Filing Date
2024-07-11
Accepted
2024-07-11 17:07:23
Documents
22

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2329561
2 filename2.htm EX-4.2 10537
3 GRAPHIC g790774g00a06.jpg GRAPHIC 72479
4 GRAPHIC g790774g00m01.jpg GRAPHIC 50970
5 GRAPHIC g790774g00s44.jpg GRAPHIC 168433
6 GRAPHIC g790774g02s97.jpg GRAPHIC 120802
7 GRAPHIC g790774g14v41.jpg GRAPHIC 88054
8 GRAPHIC g790774g40a82.jpg GRAPHIC 173862
9 GRAPHIC g790774g43a01.jpg GRAPHIC 114515
10 GRAPHIC g790774g48m48.jpg GRAPHIC 92515
11 GRAPHIC g790774g59i17.jpg GRAPHIC 92749
12 GRAPHIC g790774g70y95.jpg GRAPHIC 147456
13 GRAPHIC g790774g72d51.jpg GRAPHIC 79557
14 GRAPHIC g790774g75h77.jpg GRAPHIC 117059
15 GRAPHIC g790774g75q33.jpg GRAPHIC 59356
16 GRAPHIC g790774g77b51.jpg GRAPHIC 128130
17 GRAPHIC g790774g80i17.jpg GRAPHIC 92599
18 GRAPHIC g790774g80w10.jpg GRAPHIC 91125
19 GRAPHIC g790774g83a26.jpg GRAPHIC 85400
20 GRAPHIC g790774g84m86.jpg GRAPHIC 170745
21 GRAPHIC g790774page015.jpg GRAPHIC 426047
22 GRAPHIC g790774page016.jpg GRAPHIC 154574
  Complete submission text file 0000950123-24-006482.txt   5817493
Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Filer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-07147 | Film No.: 241112644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)